Browse our catalogue of products
4088 products displayed
| Ref-SKU | Type | Product | Description | ICTV Taxonomy | Virus name | Strain | Product Grading | Availability | Product Risk Group | Provider | Cost per Access (Academics) | More info | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 025V-04325 | Virus | Mammalian Orthoreovirus isolate 18DIAPD90107-3 isolated from faecal sample of a swine, collected in 2018 in Italy (Veneto region) | Mammalian Orthoreovirus isolate 18DIAPD90107-3 isolated from faecal sample of a swine, collected in 2018 in Italy (Veneto region) | Mammalian orthoreovirus | MRV strain 18DIAPD90107-3 | Silver | In stock | RG2 | IZSVe | 500€ | View all details on this product . . . | Free access available | |
| 025V-04359 | Virus | Mammalian Orthoreovirus isolate 18DIAPD90114-2 isolated from faecal sample of a swine, collected in 2018 in Italy (Veneto region) | Mammalian Orthoreovirus isolate 18DIAPD90114-2 isolated from faecal sample of a swine, collected in 2018 in Italy (Veneto region) | Mammalian orthoreovirus | MRV strain 18DIAPD90114/2 | Silver | In stock | RG2 | IZSVe | 500€ | View all details on this product . . . | Free access available | |
| 025V-04360 | Virus | Mammalian Orthoreovirus isolate 18DIAPD90115-3 isolated from faecal sample of a swine, collected in 2018 in Italy (Veneto region) | Mammalian Orthoreovirus isolate 18DIAPD90115-3 isolated from faecal sample of a swine, collected in 2018 in Italy (Veneto region) | Mammalian orthoreovirus | MRV strain 18DIAPD90115/3 | Silver | In stock | RG2 | IZSVe | 500€ | View all details on this product . . . | Free access available | |
| 025V-04361 | Virus | Mammalian Orthoreovirus isolate 15DIAPD53141 isolated from faecal sample of a swine, collected in 2015 in Italy (Friuli Venezia Giulia region) | Mammalian Orthoreovirus isolate 15DIAPD53141 isolated from faecal sample of a swine, collected in 2015 in Italy (Friuli Venezia Giulia region) | Mammalian orthoreovirus | MRV strain 15DIAPD53141 | Silver | In stock | RG2 | IZSVe | 500€ | View all details on this product . . . | Free access available | |
| 025V-05680 | Virus | Mammalian Orthoreovirus isolate 21DIAPD41051-3 isolated from faecal sample of a cat, collected in 2021 in Italy (Veneto) | Mammalian Othoreovirus isolate 21DIAPD41051-3 isolated from faecal sample of a cat, collected in 2021 in Italy (Veneto) | Mammalian orthoreovirus | 21DIAPD41051-3 | 21DIAPD41051-3 | Platinum | In stock | RG2 | IZSVe | 1,500€ | View all details on this product . . . | Free access available |
| 025V-05679 | Virus | Mammalian Orthoreovirus isolate 21DIAPD41049-3 isolated from faecal sample of a cat, collected in 2021 in Italy (Veneto) | Mammalian Othoreovirus isolate 21DIAPD41049-3 isolated from faecal sample of a cat, collected in 2021 in Italy (Veneto) | Mammalian orthoreovirus | 21DIAPD41049-3 | 21DIAPD41049-3 | Platinum | In stock | RG2 | IZSVe | 1,500€ | View all details on this product . . . | Free access available |
| 007S-06364 | Service | HEK293T-indE | HEK293T-indE (HEK293T-E Tet:E-IRES-ORF6) cells are a derivative of HEK293T-E with a second-generation lentiviral vector generated with the pCW57-E-IRES-ORF6 (Addgene plasmid #80921) as a transfer vector. The vector codes for SARS-COV-2 E and ORF6 under a Tetracycline inducible promoter. Cell line is needed for recovery of ∆E-based vaccine virus, which needs to be propagated on E-transcomplementing cells. | Severe acute respiratory syndrome-related coronavirus | SARS-CoV-2 | In stock | RG2 | UNIBAS | 2,500€ | View all details on this product . . . | Free access available | ||
| 007S-06365 | Service | Vero-E2T | Vero-E2T cells express SARS-CoV-2 E/ORF6/ORF7a/ORF8 genes, under the CMV promoter. Human TMPRSS2 expression in Vero-E2T was achieved by infecting the cells with a 2nd generation lentiviral vector pLEX307-TMPRSS2-blast (Addgene plasmid #158458) as a transfer vector. This cell line is needed for SARS-CoV-2 ∆E vaccine virus propagation. | Severe acute respiratory syndrome-related coronavirus | SARS-CoV-2 | In stock | RG2 | UNIBAS | 2,500€ | View all details on this product . . . | Free access available | ||
| 007V-06362 | Virus | rSARS-CoV-2_∆E-GFP_3* | Recombinant chimeric SARS-CoV-2 with a STOP codon in ORF3a. ∆E-based vaccine virus needs to be propagated on E-transcomplementing cells (Ref-SKU: 007S-06365). Green fluorescent protein (GFP) is in the coding frame of deleted SARS-CoV-2 envelope gene. Virus was obtained as described in doi: 10.1038/s41541-024-00992-z . | Severe acute respiratory syndrome-related coronavirus | SARS-CoV-2 | Wuhan | Platinum | In stock | RG3 | UNIBAS | 2,000€ | View all details on this product . . . | Free access available |
| 007V-06363 | Virus | rSARS-CoV-2_∆E-GFP_∆68 | Recombinant chimeric SARS-CoV-2 with deletion of ORF6 and ORF8. ∆E-based vaccine virus needs to be propagated on E-transcomplementing cells (Ref-SKU: 007S-06365). Green fluorescent protein (GFP) is in the coding frame of deleted SARS-CoV-2 envelope gene. Virus was obtained as described in doi: 10.1038/s41541-024-00992-z . | Severe acute respiratory syndrome-related coronavirus | SARS-CoV-2 | Wuhan | Platinum | In stock | RG3 | UNIBAS | 2,000€ | View all details on this product . . . | Free access available |
| 007V-06359 | Virus |
rSARS-CoV-2_∆E67a3*
Vaccinal strain |
Recombinant chimeric SARS-CoV-2. ∆E-based vaccine virus, needs to be propagated on E-transcomplementing cells (Ref-SKU: 007S-06365). Virus was obtained as described in doi: 10.64898/2026.03.09.709481 . | Severe acute respiratory syndrome-related coronavirus | SARS-CoV-2 | Wuhan | Platinum | In stock | RG3 | UNIBAS | 2,000€ | View all details on this product . . . | Free access available |
| 007V-06361 | Virus | rSARS-CoV-2_∆E67a 3*_esxA_XBB.1.5 | Recombinant chimeric SARS-CoV-2 with XBB.1.5 spike, expresses Mtb esxA. ∆E-based vaccine virus, needs to be propagated on E-transcomplementing cells (Ref-SKU: 007S-06365). Virus was obtained as described in doi: 10.64898/2026.03.09.709481 . | Severe acute respiratory syndrome-related coronavirus | SARS-CoV-2 | Platinum | In stock | RG3 | UNIBAS | 2,000€ | View all details on this product . . . | Free access available | |
| 007V-06360 | Virus |
rSARS-CoV-2_∆E67a3*_XBB.1.5
Vaccinal strain |
Recombinant chimeric SARS-CoV-2 with XBB.1.5 spike. ∆E-based vaccine virus, needs to be propagated on E-transcomplementing cells (Ref-SKU: 007S-06365). Virus was obtained as described in doi: 10.64898/2026.03.09.709481 . | Severe acute respiratory syndrome-related coronavirus | SARS-CoV-2 | Omicron XBB.1.5 (S only) | Platinum | In stock | RG3 | UNIBAS | 2,000€ | View all details on this product . . . | Free access available |
| 019S-06368 | Service | Advanced Training: Respiratory Syncytial Virus WGS Using Oxford Nanopore Technology | The Public Health Laboratories of Hellenic Pasteur Institute (HPI) invite laboratory professionals to an intensive 4-day hands-on training course offering cutting-edge Next-Generation Sequencing (NGS) training for Respiratory Syncytial Virus (RSV), using Oxford Nanopore Technology. This program combines high-quality sequencing analysis with practical training modules, enabling participants to confidently implement and interpret RSV genomic analysis in their home laboratories. Participants will have the opportunity to engage in real-life RSV surveillance practises at the National Influenza Reference Laboratory of Southern Greece. Participants will gain both theoretical knowledge and hands-on experience in key NGS workflows, including: 1. Viral RNA extraction for NGS applications, 2. Library preparation, 3. Operation of Oxford Nanopore platforms, 4. Data Processing Workflow: Basecalling, Alignment, and Assembly, 5. NGS data quality control and validation, 6. Basic bioinformatics pipelines for RSV genomics and variant analysis. A special rate will be offered for accommodation in a 4-star hotel located near the Hellenic Pasteur Institute. | Viruses | Human respiratory syncytial virus | Upon request | RG2 | HPI | 2,200€ | View all details on this product . . . | Free access available | ||
| 019S-06369 | Service | Advanced Training: Influenza Virus WGS Using Oxford Nanopore Technology | The Public Health Laboratories of Hellenic Pasteur Institute (HPI) invite laboratory professionals to an intensive 4-day hands-on training course offering cutting-edge Next-Generation Sequencing (NGS) training for Influenza Virus, using Oxford Nanopore Technology. This program integrates high-quality sequencing analysis with hands-on training, providing skills to generate, analyze, and interpret Influenza genomic data for research, surveillance, and diagnostics. Participants will have the opportunity to engage in real-life Influenza surveillance practises at the National Influenza Reference Laboratory of Southern Greece. Participants will gain both theoretical knowledge and hands-on experience in key NGS workflows, including: 1. Viral RNA extraction for NGS applications, 2. Library preparation, 3. Operation of Oxford Nanopore platforms, 4. Data Processing Workflow: Basecalling, Alignment, and Assembly, 5. NGS data quality control and validation, 6. Basic bioinformatics pipelines for Influenza virus genomics, 7. Bioinformatics tools for variant analysis and mutation detection. A special rate will be offered for accommodation in a 4-star hotel located near the Hellenic Pasteur Institute. | Viruses | Influenza virus | Upon request | RG2 | HPI | 2,200€ | View all details on this product . . . | Free access available | ||
| 019S-06370 | Service | Advanced Training: Influenza & RSV WGS Using Oxford Nanopore Technology | The Public Health Laboratories of Hellenic Pasteur Institute (HPI) offer a comprehensive 5-day training course on Next-Generation Sequencing (NGS) for Influenza and Respiratory Syncytial Virus (RSV), using Oxford Nanopore Technology. This course is designed to provide participants with the knowledge and practical skills required to perform whole-genome sequencing and analysis of two major respiratory viruses—Influenza and RSV—supporting surveillance, research, and diagnostic development. Participants will have the opportunity to engage in real-life Influenza and RSV practises at the National Influenza Reference Laboratory of Southern Greece. Participants will gain both theoretical knowledge and hands-on experience in key NGS workflows, including: 1. Viral RNA extraction for NGS applications, 2. Library preparation for multiplexed sequencing, 3. Operation of Oxford Nanopore platforms, 4. Data Processing Workflow: Basecalling, Alignment, and Assembly, 5. NGS data quality control and validation, 6. Basic bioinformatics pipelines for Influenza and RSV virus genomics, 7. Bioinformatics tools for variant analysis and mutation detection. A special rate will be offered for accommodation in a 4-star hotel located near the Hellenic Pasteur Institute. | Viruses | Human respiratory syncytial virus, Influenza virus | Upon request | RG2 | HPI | 2,400€ | View all details on this product . . . | Free access available | ||
| 019S-06367 | Service | Training Course: Validation & Verification of Molecular Assays for Viral Diagnostics | The Public Health Laboratories of Hellenic Pasteur Institute (HPI) invite laboratory professionals to participate in an intensive 3-day hands-on training course designed to enhance laboratory expertise in molecular diagnostics of viral infections. This comprehensive program covers the full workflow of assay validation and implementation, combining theory with practical insights. The training will be tailored to the trainee’s needs and may include: 1. Detection and typing of key viruses, 2. Validation and Verification of molecular assays (quantification by standard curve analysis, evaluation of sensitivity and specificity, determination of Limit of Detection (LOD) and Limit of Quantification (LOQ), Levey-Jennings charts), 3. Basic principles of biosafety and biosecurity, 4. Basic principles of Quality Assurance of molecular assays. A special rate will be offered for accommodation in a 4-star hotel located near the Hellenic Pasteur Institute. | Viruses | Any virus | Upon request | RG2 | HPI | 2,000€ | View all details on this product . . . | Free access available | ||
| 007V-03086 | Virus | Tick-borne encephalitis virus (strain Ljubljana) - Freeze Dried | Infectious cell culture supernatant. This Tick-borne encephalitis virus[Ljubljana] is freeze-dryed. To confirm its identity the virus has been fully sequenced. | Tick-borne encephalitis virus | tick-borne encephalitis virus 2 | Ljubljana | Platinum | In stock | RG3 | UL | 2,500€ | View all details on this product . . . | Free access available |
| 005N-06366 | Nucleic Acid | RNA of Bhanja virus, IG690 | RNA extracted from infected cell culture supernatant | Bhanja bandavirus | Bhanja virus | IG690 | In stock | No RG | UL | 500€ | View all details on this product . . . | Free access available | |
| 007V-06358 | Virus | rSARS-CoV-2_∆E67a3*_∆S/VSVG | Recombinant chimeric SARS-CoV-2, expresses VSV-G. ∆E-based vaccine virus, needs to be propagated on E-transcomplementing cells (Ref-SKU: 007S-06365). Virus was produced using the CLEVER method as described in (doi: 10.7554/eLife.89035). | Betacoronavirus | SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2 | Gold | In stock | RG3 | UNIBAS | 2,000€ | View all details on this product . . . | Free access available | |
| 007V-06357 | Virus | rSARS-CoV-2_∆E67a3*_VSVG | Recombinant chimeric SARS-CoV-2, expresses VSV-G. ∆E-based vaccine virus, needs to be propagated on E-transcomplementing cells (Ref-SKU: 007S-06365). Virus was produced using the CLEVER method as described in (doi: 10.7554/eLife.89035). | Betacoronavirus | SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2 | Gold | In stock | RG3 | UNIBAS | 2,000€ | View all details on this product . . . | Free access available | |
| 007N-06353 | Nucleic Acid | pUC19_CoV-2_ frD2 ∆E ∆orf6 orf3a* ∆orf7a/VSVG | Template for chimeric SARS-CoV-2 rescue; encodes fragment D2 of SARS-CoV-2 (nt25422-29867), with deletion of E, orf6, orf7a and a premature stop codon at position 213 in orf3a. The VSV-G gene is introduced at the locus of orf7a. ∆E-based viruses need to be rescued and propagated on E-transcomplementing cells. Full protocol for virus recovery using the CLEVER method in (10.7554/eLife.89035). | Betacoronavirus | SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2 | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 007N-06356 | Nucleic Acid | pUC19_CoV-2_ frD_∆orf3a∆E/VSVG ∆orf6 ∆orf7a | Template for chimeric SARS-CoV-2 rescue; encodes fragment D of SARS-CoV-2 (nt20950-29867), with deletion of E, orf6, orf7a, orf3a. The VSV-G gene is introduced instead of orf3a/E. ∆E-based viruses need to be rescued and propagated on E-transcomplementing cells. Full protocol for virus recovery using the CLEVER method in (10.7554/eLife.89035). | Betacoronavirus | SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2 | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 007N-06355 | Nucleic Acid | pUC19_CoV-2_ frD2_∆E ∆orf6 ∆orf7a orf3a* VSVG-P2A-N | Template for chimeric SARS-CoV-2 rescue; encodes fragment D2 of SARS-CoV-2 (nt25422-29867), with deletion of E, orf6, orf7a and a premature stop codon at position 213 in orf3a. The VSV-G gene is introduced upstream of N, separated by P2A. ∆E-based viruses need to be rescued and propagated on E-transcomplementing cells. Full protocol for virus recovery using the CLEVER method in (10.7554/eLife.89035). | Betacoronavirus | SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2 | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 007N-06354 | Nucleic Acid | pUC19_CoV-2_frD ∆S/VSVG ∆E ∆orf6 ∆orf7a orf3a* | Template for chimeric SARS-CoV-2 rescue; encodes fragment D of SARS-CoV-2 (nt20950-29867), with deletion of S, E, orf6, orf7a and a premature stop codon at position 213 in orf3a. The VSV-G gene is introduced at the locus of Spike. ∆E-based viruses need to be rescued and propagated on E-transcomplementing cells. Full protocol for virus recovery using the CLEVER method in (10.7554/eLife.89035). | Betacoronavirus | SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2 | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available |